C&R Research Past Earnings Performance
Past criteria checks 3/6
C&R Research has been growing earnings at an average annual rate of 38%, while the Life Sciences industry saw earnings growing at 21.5% annually. Revenues have been growing at an average rate of 13.7% per year. C&R Research's return on equity is 13.1%, and it has net margins of 10.1%.
Key information
38.0%
Earnings growth rate
n/a
EPS growth rate
| Life Sciences Industry Growth | 53.7% |
| Revenue growth rate | 13.7% |
| Return on equity | 13.1% |
| Net Margin | 10.1% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How C&R Research makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 55,102 | 5,549 | 46,308 | 0 |
| 30 Sep 23 | 51,587 | 3,937 | 44,465 | 0 |
| 30 Jun 23 | 50,640 | 4,272 | 43,403 | 0 |
| 31 Mar 23 | 49,699 | 3,687 | 43,256 | 0 |
| 31 Dec 22 | 48,473 | 4,021 | 41,806 | 0 |
| 30 Sep 22 | 46,857 | -2,163 | 40,479 | 0 |
| 30 Jun 22 | 45,532 | -2,614 | 39,726 | 0 |
| 31 Mar 22 | 44,986 | -3,517 | 37,620 | 0 |
| 31 Dec 21 | 43,171 | -3,301 | 35,742 | 0 |
Quality Earnings: A359090 has high quality earnings.
Growing Profit Margin: A359090's current net profit margins (10.1%) are higher than last year (8.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A359090's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare A359090's past year earnings growth to its 5-year average.
Earnings vs Industry: A359090 earnings growth over the past year (38%) exceeded the Life Sciences industry 8.1%.
Return on Equity
High ROE: A359090's Return on Equity (13.1%) is considered low.